**Question:** The following drug is NOT useful during acute attack of bronchial asthma:

A. Albuterol
B. Salbutamol
C. Theophylline
D. Nitric oxide

**Correct Answer:** D. Nitric oxide

**Core Concept:**
Acute asthma attacks involve bronchoconstriction, increased mucus production, and airway inflammation. Bronchodilators like Albuterol (Salbutamol) and Theophylline are commonly used to relax smooth muscle and reduce airway inflammation, thus improving airflow and relieving symptoms. Nitric oxide (NO) is a molecule involved in various physiological processes, including vasodilation and neurotransmission. However, NO is not typically used to treat asthma and is not considered as a bronchodilator.

**Why the Correct Answer is Right:**
Nitric oxide (NO) is primarily involved in regulating vascular tone, neurotransmission, and tissue protection. Its role in bronchodilation, which is the primary goal of treating acute asthma attacks, is not established and not widely used in clinical practice. Nitric oxide does not directly act on the smooth muscle of the airways to relax them.

**Why Each Wrong Option is Incorrect:**

A. Albuterol (Salbutamol): This is a selective beta-agonist that directly stimulates beta-2 receptors on airway smooth muscle cells, leading to increased intracellular cyclic AMP levels and relaxation of the smooth muscle.

B. Theophylline: Theophylline is an adenosine receptor antagonist and phosphodiesterase inhibitor that increases intracellular cyclic AMP levels, leading to bronchodilation and reduction in mucus secretion.

C. Albuterol (Salbutamol): Similar to option A, albuterol acts directly on beta-2 receptors and relaxes airway smooth muscle.

In contrast to NO, beta-agonists like albuterol and theophylline are proven bronchodilators used to treat acute asthma attacks. While theophylline has a longer duration of action compared to albuterol, both are essential medications in asthma management.

**Clinical Pearl:**
Nitric oxide inhalation therapy is a novel approach being researched for asthma treatment; however, it is not yet a standard treatment option for acute asthma attacks. In contrast, beta-agonists and theophylline have been proven to be effective in relieving bronchoconstriction in asthma.